IMPORTANT MESSAGE FOR TRIAL PARTICIPANTS REGARDING NATIONWIDE RECALL OF AuviQ
October 29, 2015
Dear Trial Participants,
We wanted to make sure you were informed that Sanofi US is voluntarily recalling all Auvi‑Q® (epinephrine injection, USP). The recall involves all Auvi‑Q currently on the market and includes both the 0.15 mg and 0.3 mg strengths. This includes lot number 2081278 through 3037230, which expire October 2015 through December 2016. The products have been found to potentially have inaccurate dosage delivery. [note additional lot numbers and expiration dates added November 3, 2015]
Please contact your primary care physicians or primary allergists ASAP to call in a replacement prescription for another epinephrine auto-injector. We will be happy to give you a prescription in clinic, however, due to our high volume of patients, we will not be able to call in prescriptions to your individual pharmacies.
If you have a life threatening allergic reaction and you don't have a different auto-injector available, you should still use your Auvi-Q. Then call 911 and proceed to the emergency room, and then call the on-call clinician for our Center.
Feel free to reach out to your study coordinator if you have any concerns.
The Sean N. Parker Center for Allergy & Asthma Research Team